JAKARTA - The pharmaceutical company PT Kalbe Farma Tbk recorded good performance throughout 2020. In the year of the COVID-19 pandemic, the company coded KLBF shares were able to grow in terms of revenue and net profit.
Quoting Kalbe Farma's financial report published on the disclosure page of the Indonesia Stock Exchange (IDX), Wednesday, March 31, the company owned by conglomerate Boenjamin Setiawan recorded net sales of IDR 23.11 trillion. This achievement slightly increased 2.12 percent from the 2019 period which amounted to IDR 22.63 trillion.
In terms of cost of goods sold, a slight increase was recorded at IDR 12.86 trillion, compared to IDR12.39 trillion in the previous year. Selling expenses decreased slightly to IDR 5.01 trillion, with a slight increase in general and administrative expenses to IDR 1.39 trillion, and other operating expenses which increased to IDR 156.08 billion.
As a result, the profit of this company owned by the 8th richest person in Indonesia reached IDR 2.73 trillion, an increase of 9.05 percent from the previous year which reached IDR 2.506 trillion. Basic earnings per share or earnings per share of the company in the 2020 financial year amounted to IDR 58.31, higher than 2019 which amounted to IDR 53.48.
Meanwhile, Kalbe Farma's total assets until 31 December 2020 reached IDR 22.56 trillion, an increase of 11.35 percent or IDR 2.3 trillion from the 2019 position of IDR 22.26 trillion. The main increase occurred in total current assets, which rose to IDR 13.07 trillion from the 2019 position of IDR 11.22 trillion.
This amount was primarily a result of the increase in cash and cash equivalents in the 2020 period to IDR 5.2 trillion, while in 2019 the position was IDR 3.04 trillion. Meanwhile, Kalbe Farma's total non-current assets increased to IDR 9.48 trillion from the 2019 position of IDR 9.04 trillion.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
